XML 27 R8.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements Of Cash Flows - USD ($)
$ in Millions
11 Months Ended 12 Months Ended
Jan. 01, 2016
Jan. 02, 2015
Jan. 30, 2015
Jan. 31, 2014
Cash flows from operating activities of continuing operations:        
Net income (loss) $ 242 $ (334) $ (323) $ 164
Loss (income) from discontinued operations 1 11 (7) (80)
Adjustments to reconcile net income (loss) to net cash provided by continuing operations:        
Depreciation and amortization 41 58 62 80
Stock-based compensation 30 40 42 55
Goodwill impairment charges 0 486 486 0
Asset impairment charges 33 41 81 51
Restructuring charges 3 1 3 17
(Gain) loss on a real estate sale (82) 0 0 2
Bad debt expense 3 3 5 44
Change in assets and liabilities, net of effects of acquisitions and dispositions:        
Receivables (19) 68 162 (69)
Inventory, prepaid expenses and other current assets 3 6 (12) 44
Income taxes receivable/payable 55 4 (87) 54
Deferred income taxes 26 33 56 (38)
Other assets (46) 0 2 18
Accounts payable and accrued liabilities 102 (41) (43) (87)
Accrued payroll and employee benefits 5 10 (21) (66)
Other long-term liabilities 2 (1) (10) 2
Total cash flows provided by operating activities of continuing operations 399 385 396 191
Cash flows from investing activities of continuing operations:        
Expenditures for property, plant and equipment (27) (29) (29) (53)
Acquisitions of businesses, net of cash acquired (2) 0 0 (3)
Payments on accrued purchase price related to prior acquisition (13) 0 0 0
Net proceeds from sale of assets 79 0 0 65
Proceeds from disposition of business, net of cash sold of $2 million 27 0 0 0
Proceeds from U.S. Treasury cash grant 0 80 80 0
Net proceeds of cost method investments 0 0 0 12
Dividend received from the separation of New SAIC 0 0 0 295
Contribution paid related to the separation of New SAIC 0 0 0 (26)
Other 0 0 0 7
Total cash flows provided by investing activities of continuing operations 64 51 51 297
Cash flows from financing activities of continuing operations:        
Payments on notes payable and long-term debt (39) (154) (177) (152)
Payments for deferred financing costs 0 0 0 (5)
Payment from New SAIC for deferred financing costs 0 0 0 5
Proceeds from real estate financing transaction 0 0 0 38
Payments on real estate financing transaction (8) 0 0 0
Proceeds from debt issuance 0 0 0 500
Distribution of debt to New SAIC 0 0 0 (500)
Sales of stock and exercises of stock options 6 7 7 13
Repurchases of stock and stock received for tax withholdings (118) (213) (215) (319)
Dividend payments (93) (72) (95) (477)
Other 3 1 2 3
Total cash flows used in financing activities of continuing operations (249) (431) (478) (894)
Increase (decrease) in cash and cash equivalents from continuing operations 214 5 (31) (406)
Cash flows from discontinued operations:        
(Decrease) increase in cash and cash equivalents from discontinued operations (7) (5) 15 118
Cash (used in) provided by operating activities of discontinued operations 6 29 29 (17)
(Decrease) increase in cash and cash equivalents from discontinued operations (1) 24 44 101
Total increase (decrease) in cash and cash equivalents 213 29 13 (305)
Cash and cash equivalents at beginning of year 443 430 430 735
Cash and cash equivalents at end of year 656 459 443 430
Leidos, Inc.        
Cash flows from operating activities of continuing operations:        
Net income (loss) 248 (328) (317) 166
Loss (income) from discontinued operations 1 11 (7) (80)
Adjustments to reconcile net income (loss) to net cash provided by continuing operations:        
Depreciation and amortization 41 58 62 80
Stock-based compensation 30 40 42 55
Goodwill impairment charges 0 486 486 0
Asset impairment charges 33 41 81 51
Restructuring charges 3 1 3 17
(Gain) loss on a real estate sale (82) 0 0 2
Bad debt expense (3) (3) (1) 42
Change in assets and liabilities, net of effects of acquisitions and dispositions:        
Receivables (19) 68 162 (69)
Inventory, prepaid expenses and other current assets 3 6 (12) 44
Income taxes receivable/payable 55 4 (87) 54
Deferred income taxes 26 33 56 (38)
Other assets (46) 0 2 18
Accounts payable and accrued liabilities 102 (41) (43) (87)
Accrued payroll and employee benefits 5 10 (21) (66)
Other long-term liabilities 2 (1) (10) 2
Total cash flows provided by operating activities of continuing operations 399 385 396 191
Cash flows from investing activities of continuing operations:        
Proceeds on obligations of Leidos Holdings, Inc. 9 142 156 13
Payments on obligations of Leidos Holdings, Inc. (211) (419) (457) (501)
Expenditures for property, plant and equipment (27) (29) (29) (53)
Acquisitions of businesses, net of cash acquired (2) 0 0 (3)
Payments on accrued purchase price related to prior acquisition (13) 0 0 0
Net proceeds from sale of assets 79 0 0 65
Proceeds from disposition of business, net of cash sold of $2 million 27 0 0 0
Proceeds from U.S. Treasury cash grant 0 80 80 0
Net proceeds of cost method investments 0 0 0 12
Contribution paid related to the separation of New SAIC 0 0 0 (26)
Other 0 0 0 7
Total cash flows provided by investing activities of continuing operations (138) (226) (250) (486)
Cash flows from financing activities of continuing operations:        
Payments on notes payable and long-term debt (39) (154) (177) (152)
Payments for deferred financing costs 0 0 0 (5)
Payment from New SAIC for deferred financing costs 0 0 0 5
Proceeds from real estate financing transaction 0 0 0 38
Payments on real estate financing transaction (8) 0 0 0
Other 0 0 0 3
Total cash flows used in financing activities of continuing operations (47) (154) (177) (111)
Increase (decrease) in cash and cash equivalents from continuing operations 214 5 (31) (406)
Cash flows from discontinued operations:        
(Decrease) increase in cash and cash equivalents from discontinued operations (7) (5) 15 118
Cash (used in) provided by operating activities of discontinued operations 6 29 29 (17)
(Decrease) increase in cash and cash equivalents from discontinued operations (1) 24 44 101
Total increase (decrease) in cash and cash equivalents 213 29 13 (305)
Cash and cash equivalents at beginning of year 443 430 430 735
Cash and cash equivalents at end of year $ 656 $ 459 $ 443 $ 430